← Leaderboards
Michael Bouvet
University Of California, San Diego
$7,522,814
Attributed
$12,762,572
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,762,572 · 8
VA$0 · 4
By mechanism
R01$7,293,449 · 4
T32$4,176,431 · 1
R21$715,386 · 2
R33$577,306 · 1
I01$0 · 4
Top collaborators
- Meng Yang16 shared
- Surinder Kumar Batra4 shared
- Dwayne G Stupack4 shared
- Punita Dhawan3 shared
- Maged M Henary3 shared
- Hak Soo Choi2 shared
- Satoshi Kashiwagi1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Richard Ting$903,978
- Sasan Moghimi Araghi$1,984,890
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorImageMouse ModelLabelMalignant NeoplasmsIn VivoNeoplasm MetastasisFluorescence ImagingTissuesFluorescenceOperative Surgical ProceduresAntibodiesMalignant Neoplasm Of PancreasDetectionExcisionMonoclonal AntibodiesPancreasAntibody ConjugateSurvival RateLaboratoriesImaging TechnologyCancer EtiologyFluorophoreAnimal Model
Grant awards (49)
Targeting parathyroid glands with novel fluorophores for intraoperative imaging$699,269
R01 · FY2025 · CA
UCSD Cancer Center Training Program in Drug Development$510,659
T32 · FY2025 · CA · contact PI
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer$450,008
R01 · FY2025 · CA · contact PI
Novel Tools for Colon Cancer Detection and Therapy$0
I01 · FY2025 · VA
BCCMA: VA Colorectal Cancer Clinical & Computational Collaborative (VA-5C): NIR-labeled antibodies to target and label colon polyps and cancer for improved diagnosis and surgery$0
I01 · FY2025 · VA · contact PI
Targeting parathyroid glands with novel fluorophores for intraoperative imaging$664,306
R01 · FY2024 · CA
UCSD Cancer Center Training Program in Drug Development$660,886
T32 · FY2024 · CA · contact PI
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer$427,508
R01 · FY2024 · CA · contact PI
Novel Tools for Colon Cancer Detection and Therapy$0
I01 · FY2024 · VA
Targeting parathyroid glands with novel fluorophores for intraoperative imaging$733,271
R01 · FY2023 · CA
UCSD Cancer Center Training Program in Drug Development$678,502
T32 · FY2023 · CA · contact PI
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer$441,011
R01 · FY2023 · CA · contact PI
CMA- Marker-assisted prevention and risk stratification (MAPRS): Mucin signatures and molecular imaging for the early detection of colorectal cancer.$0
I01 · FY2023 · VA · contact PI
Novel Tools for Colon Cancer Detection and Therapy$0
I01 · FY2023 · VA
UCSD Cancer Center Training Program in Drug Development$637,071
T32 · FY2022 · CA · contact PI
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer$464,170
R01 · FY2022 · CA · contact PI
Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers$0
I01 · FY2022 · VA · contact PI
CMA- Marker-assisted prevention and risk stratification (MAPRS): Mucin signatures and molecular imaging for the early detection of colorectal cancer.$0
I01 · FY2022 · VA · contact PI
CMA- Marker-assisted prevention and risk stratification (MAPRS): Mucin signatures and molecular imaging for the early detection of colorectal cancer.$0
I01 · FY2021 · VA · contact PI
Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers$0
I01 · FY2021 · VA · contact PI
UCSD Cancer Center Training Program in Drug Development$595,993
T32 · FY2020 · CA · contact PI
CMA- Marker-assisted prevention and risk stratification (MAPRS): Mucin signatures and molecular imaging for the early detection of colorectal cancer.$0
I01 · FY2020 · VA · contact PI
Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers$0
I01 · FY2020 · VA · contact PI
UCSD Cancer Center Training Program in Drug Development$523,409
T32 · FY2019 · CA · contact PI
Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers$0
I01 · FY2019 · VA · contact PI
UCSD Cancer Center Training Program in Drug Development$569,911
T32 · FY2018 · CA · contact PI
Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers$0
I01 · FY2018 · VA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$79,602
R01 · FY2015 · CA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$300,912
R01 · FY2014 · CA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$111,922
R01 · FY2014 · CA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$291,606
R01 · FY2013 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$278,595
R01 · FY2013 · CA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$310,115
R01 · FY2012 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$296,378
R01 · FY2012 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$25,220
R01 · FY2012 · CA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$309,594
R01 · FY2011 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$296,378
R01 · FY2011 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$47,311
R01 · FY2011 · CA · contact PI
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors$319,169
R01 · FY2010 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$305,544
R01 · FY2010 · CA · contact PI
Divalent cation activation of the integrin-mediated malignant phenotype in pancre$169,950
R21 · FY2010 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$22,491
R01 · FY2010 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$319,169
R01 · FY2009 · CA · contact PI
Divalent cation activation of the integrin-mediated malignant phenotype in pancre$203,940
R21 · FY2009 · CA · contact PI
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery$99,900
R01 · FY2009 · CA · contact PI
Imageable Mouse Models of Pancreatic Cancer$290,041
R33 · FY2008 · CA · contact PI
Imageable Mouse Models of Pancreatic Cancer$287,265
R33 · FY2007 · CA · contact PI
Imageable Mouse Models of Pancreatic Cancer$173,344
R21 · FY2005 · CA
Imageable Mouse Models of Pancreatic Cancer$168,152
R21 · FY2004 · CA